Investigating Isthmin as an adipose-to-muscle messenger that promotes muscle protein synthesis

研究 Isthmin 作为促进肌肉蛋白质合成的脂肪到肌肉信使

基本信息

  • 批准号:
    10664500
  • 负责人:
  • 金额:
    $ 9.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-04-14 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT Metabolic stressors and pathologic conditions such as diabetes can lead to pronounced physiologic alterations in protein regulation, resulting in muscle atrophy, which is highly associated with morbidity. However, the mechanisms underlying this association remain elusive. Understanding the mechanisms of maintaining muscle protein content is crucial to improving insulin resistance and overall metabolic health. Adipose tissue is an endocrine organ that responds to acute and chronic energetically challenging conditions by secreting proteins, referred to as adipokines. Evidence suggests that signaling mediated by adipokines plays a crucial role in organ crosstalk and systemic energy metabolism. Because of their direct signaling action, they can be developed as therapeutic agents for metabolic diseases. While considerable effort has been made to target the adipose tissue as a component of insulin resistance, the involvement of adipokines in muscle physiology is understudied. My research training plan will leverage endocrinology, muscle biology, bioinformatics, and newly generated genetic mouse models as a toolkit to investigate the function and mechanisms of a previously understudied hormone in promoting muscle growth with potentially fewer side effects. This proposal tests the central hypothesis that Isthmin-1 (Ism1) mediates adipose-muscle crosstalk that regulates muscle proteostasis. The following aims are proposed: Aim 1: To determine whether Ism1 mediates muscle growth through adipose-muscle crosstalk. Aim 2: To determine whether Ism1 alters balance between muscle protein synthesis and degradation. Aim 3: Using phosphoproteomics to discover novel pathways that regulate muscle proteostasis. If successful, this research will establish a novel adipose-muscle pathway in muscle growth with potential future therapeutic implications, since the Ism1 hormone itself can be used as a direct pharmacologic treatment for atrophy and disorders for which exercise is not an option. This project will also provide training for Dr. Zhao’s long-term goal as an independent investigator to dissect the hormonal crosstalk between metabolic organs to improve metabolic diseases. The candidate Dr. Zhao has extensive and suitable prior training in metabolic physiology, with 13 publications including 5 as first- author since 2016. The Career Development Plan is tailored to enable Dr. Zhao to gain new experimental skills and concepts in muscle biology, biochemistry, and endocrine signaling from expert physiologists, endocrinologists, and biochemists in the mentoring team. The environment at Stanford University is unparalleled for collaborative and innovative research and career development training. In summary, the strong mentoring environment and training plan are anticipated to fully prepare Dr. Zhao to launch her independent career. The proposed studies promise to offer mechanistic insights into adipose-muscle crosstalk to identify therapeutic targets that can counter muscle protein loss and associated metabolic disease.
摘要 代谢应激源和糖尿病等病理情况会导致明显的生理变化。 在蛋白质调节中,导致肌肉萎缩,这与发病率高度相关。然而, 这种联系背后的机制仍然难以捉摸。了解维持肌肉的机制 蛋白质含量对改善胰岛素抵抗和整体新陈代谢健康至关重要。脂肪组织是一种 内分泌器官,通过分泌蛋白质来对急性和慢性能量挑战条件做出反应, 被称为脂肪因子。有证据表明,脂肪因子介导的信号在器官中起着至关重要的作用 串扰和全身能量代谢。由于它们的直接信号作用,它们可以发展为 代谢性疾病的治疗剂。虽然已经做出了相当大的努力来靶向脂肪组织 作为胰岛素抵抗的一个组成部分,脂肪因子在肌肉生理学中的作用尚未得到充分研究。我的 研究培训计划将利用内分泌学、肌肉生物学、生物信息学和新产生的基因 小鼠模型作为工具箱来研究以前未被研究的激素的功能和机制 促进肌肉生长,副作用更少。这一提议检验了核心假设,即 Isthmin-1(ISM1)介导脂肪-肌肉串扰,调节肌肉蛋白平衡。以下是目标 建议:目的1:确定ISM1是否通过脂肪-肌肉串扰来调节肌肉生长。目标 2:确定ISM1是否改变了肌肉蛋白质合成和降解之间的平衡。目标3:使用 磷酸蛋白质组学,以发现调节肌肉蛋白平衡的新途径。如果成功,这项研究 将在肌肉生长中建立一种新的脂肪-肌肉途径,具有潜在的未来治疗意义, 由于ISM1激素本身可以用作治疗萎缩和疾病的直接药物治疗 哪种锻炼不是一种选择。 该项目还将为赵博士作为独立调查员的长期目标提供培训 剖析代谢器官之间的荷尔蒙串扰,以改善代谢性疾病。这位候选人是Dr。 赵先生曾接受过广泛和适当的代谢生理学培训,发表了13篇论文,其中5篇是首次发表- 自2016年以来一直是作者。职业发展计划是为了让赵博士获得新的实验技能而量身定做的 以及来自专业生理学家的肌肉生物学、生化和内分泌信号方面的概念, 指导团队中的内分泌学家和生物化学家。斯坦福大学的环境是无与伦比的 用于协作和创新的研究和职业发展培训。总而言之,强大的导师 环境和培训计划预计将为赵博士开始她的独立职业生涯做好充分准备。这个 拟议的研究承诺提供对脂肪-肌肉串扰的机械性见解,以确定治疗方法 可以对抗肌肉蛋白质丢失和相关代谢性疾病的靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Meng Zhao其他文献

Meng Zhao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Meng Zhao', 18)}}的其他基金

The role of mitochondrial regulation in cell lineage specification and function
线粒体调节在细胞谱系规范和功能中的作用
  • 批准号:
    10798885
  • 财政年份:
    2022
  • 资助金额:
    $ 9.08万
  • 项目类别:
The role of mitochondrial regulation in cell lineage specification and function
线粒体调节在细胞谱系规范和功能中的作用
  • 批准号:
    10501649
  • 财政年份:
    2022
  • 资助金额:
    $ 9.08万
  • 项目类别:
The role of mitochondrial regulation in cell lineage specification and function
线粒体调节在细胞谱系规范和功能中的作用
  • 批准号:
    10818978
  • 财政年份:
    2022
  • 资助金额:
    $ 9.08万
  • 项目类别:
Role of purinergic receptor P2X7 in the differentiation and function of iNKT cell subsets
嘌呤能受体P2X7在iNKT细胞亚群分化和功能中的作用
  • 批准号:
    10339355
  • 财政年份:
    2021
  • 资助金额:
    $ 9.08万
  • 项目类别:
Role of purinergic receptor P2X7 in the differentiation and function of iNKT cell subsets
嘌呤能受体P2X7在iNKT细胞亚群分化和功能中的作用
  • 批准号:
    10090983
  • 财政年份:
    2021
  • 资助金额:
    $ 9.08万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.08万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.08万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 9.08万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.08万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.08万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.08万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.08万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 9.08万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 9.08万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 9.08万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了